BRIAN A MARKISON
CIK 1283061 · CEO · last filed 2025-03-07
BRIAN A MARKISON is a CEO who has filed 90 SEC Form 4 insider transactions across 9 companies since 2007. The most recent filing, for LNTH, was dated Mar 7, 2025. Across all open-market trades the lifetime net is −$6.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $26.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$26.64M
9
90
-$6.19M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LNTH | CEO | 232,420 | $104.52 | $24.29M | -$6.52M | 32 | 2025-03-07 |
| RVL Pharmaceuticals plc (RVLP) Delisted | Chief Executive Officer | 2,976,020 | $0.03 | $83.9K | $1.32M | 1 | 2022-08-09 |
| RVL Pharmaceuticals plc (OSMT) Delisted | Chief Executive Officer | 2,126,020 | $1.11 | $2.36M | $0 | 3 | 2021-11-08 |
| Organogenesis Holdings Inc. (AHPAW) Delisted | Director | — | $0.69 | — | $0 | 5 | 2018-12-12 |
| IMMUNOMEDICS INC (IMMU) Delisted | Director | 90,788 | — | — | -$167.8K | 16 | 2017-11-21 |
| ALERE INC. (ALRpB) Delisted | Director | 0 | — | — | $0 | 4 | 2017-10-03 |
| Organogenesis Holdings Inc. (AHPAU) Delisted | Director | — | $6.16 | — | $0 | 1 | 2016-11-29 |
| Altimmune, Inc. (PIP) Delisted | Director | — | — | — | $0 | 4 | 2015-01-05 |
| KG | President and CEO | 200,760 | $11.68 | $2.34M | -$817.7K | 24 | 2011-02-02 |
Recent Filings
90 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-07 | LNTH | Grant (A) | +70,909 | $0 | EDGAR |
| 2025-03-05 | LNTH | Tax (F) | −8,637 | -$819.3K | EDGAR |
| 2024-12-23 | LNTH | Mixed | +17,322 | -$1.11M | EDGAR |
| 2024-03-05 | LNTH | Grant (A) | +131,496 | $0 | EDGAR |
| 2023-05-15 | LNTH | Grant (A) | +2,012 | $0 | EDGAR |
| 2023-03-29 | LNTH | Sell (S) | −13,290 | -$1.08M | EDGAR |
| 2022-09-12 | LNTH | Mixed | −17,360 | -$3.07M | EDGAR |
| 2022-09-08 | LNTH | Mixed | — | -$99.4K | EDGAR |
| 2022-08-09 | RVL Pharmaceuticals plc (RVLP) Delisted | Buy (P) | +850,000 | $1.32M | EDGAR |
| 2022-05-12 | LNTH | Grant (A) | — | $0 | EDGAR |